WIM
XTNT icon

Wiregrass Investment Management’s Xtant Medical Holdings XTNT Stock Holding History

Wiregrass Investment Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Buy
150,000
+47,000
+46% +$22.6K 0.04% 111
2026
Q1 		$57.5K Hold
103,000
– – 0.05% 95
2025
Q4 		$80.8K Buy
+103,000
New +$74.8K 0.07% 97

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wiregrass Investment Management's XTNT Position: Q2 2026 in Review

Wiregrass Investment Management increased its Xtant Medical Holdings (XTNT) stake by 46% in Q2 2026, buying an estimated $22.6K and bringing the position to 150,000 shares worth $63.1K. The position accounts for 0.04% of the portfolio, ranked #111.

Wiregrass Investment Management first reported a position in XTNT in Q4 2025 and has held it in 3 quarters since. The position peaked at $80.8K in Q4 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

  • Wiregrass Investment Management held 150,000 shares of Xtant Medical Holdings worth $63.1K as of Q2 2026.
  • Wiregrass Investment Management bought 47,000 Xtant Medical Holdings shares in Q2 2026, an estimated $22.6K.
  • Xtant Medical Holdings made up 0.04% of Wiregrass Investment Management's portfolio in Q2 2026, its #111 holding.
  • Wiregrass Investment Management first reported a position in Xtant Medical Holdings in Q4 2025 and has held it in 3 quarters since.
  • Wiregrass Investment Management's Xtant Medical Holdings position peaked at $80.8K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Wiregrass Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.